Interstitial cells: regulators of smooth muscle function

KM Sanders, SM Ward, SD Koh - Physiological reviews, 2014 - journals.physiology.org
Smooth muscles are complex tissues containing a variety of cells in addition to muscle cells.
Interstitial cells of mesenchymal origin interact with and form electrical connectivity with …

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

P Abrams, KE Andersson, JJ Buccafusco… - British journal of …, 2006 - Wiley Online Library
1 The effectiveness of antimuscarinic agents in the treatment of the overactive bladder (OAB)
syndrome is thought to arise through blockade of bladder muscarinic receptors located on …

Antimuscarinics for treatment of overactive bladder

KE Andersson - The Lancet Neurology, 2004 - thelancet.com
For many years, antimuscarinic drugs have been the first-line pharmacological treatment for
urgency, frequency, and urge incontinence, all symptoms of the disorder termed overactive …

[PDF][PDF] The pharmacological treatment of urinary incontinence

KE Andersson, R Appell, LD Cardozo, C Chapple… - BJU …, 1999 - academia.edu
The pharmacological treatment of urinary incontinence Page 1 BJU International (1999), 84,
923–947 REVIEW The pharmacological treatment of urinary incontinence K.-E …

Current and emerging pharmacological targets and treatments of urinary incontinence and related disorders

MC Michel, L Cardozo, CJ Chermansky, F Cruz… - Pharmacological …, 2023 - ASPET
Overactive bladder syndrome with and without urinary incontinence and related conditions,
signs, and disorders such as detrusor overactivity, neurogenic lower urinary tract …

Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects

G Kay, T Crook, L Rekeda, R Lima, U Ebinger… - European urology, 2006 - Elsevier
OBJECTIVES: To investigate the effects of darifenacin controlled-release (CR) and
oxybutynin extended-release (ER) on cognitive function (particularly memory) in older …

Muscarinic receptors in the bladder: from basic research to therapeutics

SS Hegde - British journal of pharmacology, 2006 - Wiley Online Library
Muscarinic receptor antagonists (antimuscarinics) serve as the cornerstone in the
pharmacological management of overactive bladder (OAB) by relieving the symptoms of …

Antimuscarinics and the overactive detrusor—which is the main mechanism of action?

KE Andersson, M Yoshida - European urology, 2003 - Elsevier
Contraction of the bladder, voluntary or involuntary, involves stimulation of the muscarinic
receptors on the detrusor by acetylcholine, released from activated cholinergic nerves …

Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan

AO D'Souza, MJ Smith, LA Miller, J Doyle… - Journal of Managed Care …, 2008 - jmcp.org
BACKGROUND: Pharmacotherapy constitutes an important adjunct to behavioral therapy for
the treatment of overactive bladder (OAB). Tolterodine and oxybutynin are commonly …

[HTML][HTML] Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT–PCR: changes in …

KJ Mansfield, L Liu, FJ Mitchelson… - British journal of …, 2005 - ncbi.nlm.nih.gov
We investigated muscarinic receptors in the detrusor and mucosa of the human bladder
body. Radioligand-binding studies with [3 H] QNB were conducted using specimens …